Perhaps one of the single most crucial decisions for a pharma company can be the selection of an API supplier. This, by itself, cannot be viewed as a ‘simple commodity purchase’, as it cannot escape from product quality and impacts, on the basis of the characteristics and requirements of the drug product of quality, consistency, control and tractability from within a controlled manufacturing processes and systems. Quality, in consequence for this consideration has come to have a major effect as to the decision Making.
By pharmaceutical companies, quality has become a key element, coupled now with aspects of: manufacturing capability; supported by documented evidence; the suppliers regulatory track;; history, and supply integrity and also product quality management systems.
The fundamental criteria for this evaluation have been provided by aspects of regulation and ICH Q7, which gives GMP criteria relevant to API manufacture, and guides the alignment of these systems and factors to address API quality attributes and ensure suitability, and an agreed level of quality, and purity criteria as part. The API supplier who offers the product at, for instance, the cheapest price, should not be favoured as a favoured partner if they cannot provide a consistent, guaranteed quality product and appropriate commercial and regulatory back up when needed.
What Does Regulatory Compliance Mean for an API Supplier?
Regulatory Compliance (RC) means abiding by the laws, regulations, standards and quality guidelines applicable to pharmaceutical manufacture and supply chain activities. For an API manufacturers this can include starting materials receipt and handling, their own production, quality control and product specification, packaging, warehousing, shipping etc.
ICH Q7 clearly specifies the elements that relate to these areas under its GMP guidelines.
RC shouldn’t just be a certificate on the wall;it requires established written procedures and process documentation, qualified staff, adequate and controlled process infrastructure, effective testing, quality investigations and quality oversight, and appropriate batch and supply chain tracking etc. However the actual RC will differ greatly for a drug on a European market verses North American market,for use in an ‘essential use drug versus novel biological,’ or for a API used solely in veterinary drugs and so the buyer should tailor their check against their own target market, use and quality parameters.
Why Compliance Matters in API Supplier Selection
Compliance-This is the ability to determine if a potential supplier is capable of the systems to manufacture a constant quality of material.
A qualified supplier can reduce the risks associated with:
* Unforeseen changes in material quality
* Inadequate documentation
* Undocumented process changes
* Undocumented contamination and cross-contamination
* Loss of traceability
* Disruptions in supply
* Regulatory problems
The FDA Q7 guidance recommends that the process of supplier approval include verification that the manufacturer is capable of providing material of the required specifications on a reproducible and consistent basis and lists annual review of the reliability and Certificates of Analysis of suppliers.
This makes obvious why supplier qualification should be based on evidence, not on the marketing efforts of the supplier.
GMP and Quality Management Systems
The quality management system should be one of the key factors to assess a GMP compliant API supplier.
An effective quality management system might comprise of:
Standard operating procedures
Training of personnel
Batch manufacture records
Laboratory controls
Change control
Deviation investigations
CAPA
Internal audits
Equipment qualification
Process validation where appropriate
Complaint handling
Product quality review
The quality function should possess sufficient independence and responsibility. Examples include the review and approval of quality documents, approval of specification, the investigation of critical deviations, and approval or rejection of APIs.
By scrutinising these systems, a buyer of pharmaceuticals may develop a greater appreciation of how a supplier controls quality in their operations.
The Importance of API Documentation
It all matters in Supplier qualification One of the biggest items in APi supplier qualification is Documentation. A buyer might need: Certificate of analysis Product specifications Safety Data Sheet Manufacturing data The process description Analytical data and/or methods Data on stability or retest Date of Manufacture Material Identification Data (for traceable items) Relevant certifications on packaging Regulatory documents Documentation provides ability to the customer to check incoming material against desired specifications, and keep adequate documents. FDA states that reliable Certificate of analysis and sound documentation are essential to the effective establishment and use of robust supplier evaluation process for API manufacturing and suppliers can have significant impact in API manufacturing. Documentation is vital for international companies that need to meet specific requirements for their importing country as they might be different from their home countries.
Supplier Audits and Qualification
Many pharmaceutical companies will visit supplier sites prior to agreeing to contract a new source for an API. As you can see from a site audit you can assess the reality of their system, instead of relying on paperwork alone. For a typical review you might consider:
MANUFACTURING :
Are manufacturing systems correctly documented and controlled?
QUALITY CONTROL
Is their laboratory set up with the appropriate testing procedures and controls in place?
QUALITY ASSURANCE
Is their process for managing deviations, changes, complaints and CAPA well-documented and controlled?
TRACEABILITY
can batches and relevant manufacturing records be linked?
FACILITIES & EQUIPMENT
are the critical equipment and systems adequately maintained and qualified?
PERSONNEL
are the staff suitably trained to conduct their roles?
are the staff suitably trained to conduct their roles?
I should also point out that ICHQ7 says companies should assess contractors when they perform certain operations onsite.
Certifications Are Important—but Not the Whole Story
While accreditations, certifications, audit history and approval may offer insights into the capabilities and reliability of a potential supplier, Buyers must confirm the scope and currency of these qualifications, as well as the credentials of issuing agencies and their relevance to the products and services offered. A simple certificate is not sufficient without qualification of the supplier. Companies involved in Pharmaceuticals must review the entire value chain – including manufacturing controls, quality systems, product testing, record keeping, regulatory record and the past performance of the supplier. This becomes particularly significant when evaluating suppliers from different regions of the world, serving varied global regulatory environments.
Product Specifications and Quality Standards
There should be clear and appropriate product specifications. “Product specifications” should reflect the product, including suitable references to pharmacopoeias (e.g. USP, BP, EP, IP or equivalent) where appropriate.
“What the specification entails may relate to the API’s identification, assay, related substances and impurities (organic and inorganic), residual solvents, water or moisture, and physical parameters.
There may also be microbiological criteria where the API may not meet standard chemical specifications.” The appropriate level of specification will depend on both the product, the particular client and the regulatory market involved. There is existing EMA guidance relating to active substances: the Q&A document for ‘Active substances used in medicinal products’ contains detailed recommendations for, among others, control, the manufacturing process and specifications and the nature of an Active Substance’s specification.
Regulatory Compliance for Global API Sourcing
Global sourcing is yet another complicating factor. A supplier may be called upon to serve customers whose activities would fall under several varied systems of regulation. US FDA would govern active ingredients being imported to US as part of pharmaceutical supplies (and would likely call on regulations concerning foreign establishment practices and drug listings) while the similar pharmaceutical ingredients landing on shores in Europe must adhere to European regulatory standards and European expectations as to active ingredient quality standards.
This brings into play a critical and logical question an international buyer must pose to his potential supplier: “Can this supplier meet my supply needs based on standards imposed by my market?”
Answers to this should rely on evidence, not estimation.
Red Flags When Selecting an API Supplier
A few more things to investigate more thoroughly prior to accepting a supplier: IncompleteDocumentation Vague specifications or certificates and/or incomplete/conflicting data makes qualifying the supplier problematic. Non-verifiable Certification Appropriate supporting documentation must be available from the supplier regarding any certifications or claims of adherence to any regulatory guidance. Unclear Origin Of Manufacturing The buyer should know who manufactures the API itself rather than having any intermediary or distributors present themselves as manufacturers (especially for third part purchased materials).
Bad Quality Communication slow and or lack of responsiveness to technical queries will come back to haunt later on in life.
Mysterious Quality Inconsistency Variations from batch-to-batch should never be dismissed but instead followed-up on. Poor traceability If they can’t give me the right information in support of my traceability of my received material then they should be dropped immediately.
How Compliance Can Reduce Long-Term Risk
While appropriate selection and thorough qualification can’t remove all quality or supply risk; it can significantly improve a pharmaceutical company’s entire risk management process:
A fully qualified supplier may enhance:
More reliable product quality
Better records and documentation
Simpler supplier audits
Enhanced readiness for regulatory inspection
Improved traceability of components/products
More productive quality investigations
More efficient supply planning
Supplier qualification, furthermore, should remain a continuous process; not something that terminates with initial qualification. Performance, complaints, deviations, quality trends and deliveries can be examined on an on-going basis to ensure supplier suitability.
Prism Industries Pvt. Ltd. as an API Supply Partner
Manufacturing and supply of quality-driven pharmaceutical APIs by Prism Industries Pvt Ltd Prism Industries endeavors to enhance product quality by adhering to established standards. When you are considering an API Manufacturer India, several aspects need due diligence as including a company’s manufacturing strength, consistent products, relevant documentation, product specifications, company-customer communication and supply chain reliability. Prism Industries aims to leverage a service-oriented quality-based method for selling and marketing API that helps in creating sustained company relationships with pharmaceutical consumers.
Prism’s mission is to create high-value business opportunities for international buyers by matching their supply Chain and regulatory needs with global manufacturing practices.
An international buyer selecting a supplier will do it looking for the product range in the market it serves as well as market value, global compliance and the qualification procedures it uses in your global supply network.
Practical API Supplier Selection Checklist
Before approving an API supplier, pharmaceutical procurement and quality teams can consider:
✅ Manufacturing capability
✅ Applicable GMP systems
✅ Quality-control procedures
✅ Product specifications
✅ Analytical testing
✅ Certificate of Analysis reliability
✅ Regulatory documentation
✅ Supplier audit findings
✅ Change-control procedures
✅ Deviation and CAPA management
✅ Traceability
✅ Supply reliability
✅ Technical support
✅ Customer communication
This structured approach can help organizations make supplier decisions based on evidence rather than price alone.
Conclusion
The supplier will definitely look to regulatory compliance as number one. This is because from a pharmaceutical manufacturer’s perspective I want the comfort of knowing that I am going to get what I have specified and I am going to get it reliably, under quality specifications agreed at contract. By best practice, I’m evaluating strength; regulatory compliance; a manufacturing capability; good quality product; comprehensive documentation; and where applicable a strong team; reliable supply and excellent customer support.
So compliance needs to be more than just a part of what’s demanded by the regulators.
I think it is becoming one part of what’s demanded by a future look of customer confidence with our suppliers. For businesses that use APIs, the decision about their supplier will finally be about the creation of a working relationship around these things, around quality; around consistency and around meeting both regulatory expectations and those of our business continuity.
At Prism Industries Pvt. Ltd., we are proud to support such efforts by providing trusted, compliant APIs to innovators in the global pharmaceutical space.
To explore quinine for advanced therapeutic research, contact us today at www.prisminltd.com.
Contact us at www.prisminltd.com/contact to learn more or request a product sample.
Explore Our Products: https://prisminltd.com/products/
Follow us on:
Facebook: https://www.facebook.com/profile.php?id=61559713707912&is_tour_dismissed
Twitter: https://x.com/prismindltd
Linkedin: https://www.linkedin.com/in/prism-industries-589771309/
Instagram : https://www.instagram.com/prism2241
FAQs:
Regulatory compliance helps pharmaceutical companies evaluate whether an API supplier has appropriate systems for manufacturing, testing, documenting, and controlling pharmaceutical ingredients.
Review manufacturing capability, GMP systems, specifications, analytical testing, documentation, supplier audit results, regulatory information, traceability, supply reliability, and technical support.
No. A certificate can be useful evidence, but supplier qualification should also consider the certificate’s scope and validity, manufacturing practices, product quality, documentation, audit findings, and ongoing performance.
A Certificate of Analysis provides batch-specific analytical information and helps customers evaluate whether supplied material meets established specifications. Its reliability should also be appropriately assessed.
An audit can be an important part of supplier qualification, particularly when the API is critical or the supplier’s manufacturing and quality systems require direct assessment.
Yes. Regulatory and documentation requirements can vary by market. For example, APIs imported into the United States are subject to applicable FDA requirements, while European markets have their own regulatory frameworks.
A reliable supplier combines appropriate quality systems, consistent products, proper documentation, regulatory awareness, dependable supply, effective communication, and the ability to meet customer-specific requirements.
Yes. Strong supplier qualification and quality systems can help identify potential quality and regulatory risks earlier, although they cannot eliminate every possible supply-chain disruption.